Long-term safety of sarilumab

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-019-65435-3
中图分类号
学科分类号
摘要
引用
收藏
页码:11 / 11
相关论文
共 50 条
  • [21] Long-term safety of budesonide
    Lichtenstein, GR
    Bengtsson, B
    Hapten-White, L
    GASTROENTEROLOGY, 2004, 126 (04) : A466 - A466
  • [22] Long-term safety of MorphiDex®
    Goldblum, R
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 19 (01) : S50 - S56
  • [23] Safety: a long-term view
    Houlton, Sarah
    CHEMISTRY & INDUSTRY, 2012, 76 (06) : 21 - 21
  • [24] SAFETY OF LONG-TERM STEROIDS
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1971, 2 (5761): : 583 - +
  • [25] LONG-TERM SAFETY OF ISOTRETINOIN
    CUNLIFFE, WJ
    DERMATOLOGICA, 1984, 169 (04): : 255 - 255
  • [26] Safety of long-term alendronate
    Tonino, RP
    Santora, A
    Ross, PD
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04): : 1835 - 1836
  • [27] The long-term safety of sertindole
    Ramirez, L
    Foley, S
    Dawson, M
    Zylberman, K
    Mack, R
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 68 - 68
  • [28] Safety and Efficacy of Long-term Sarilumab Treatment in Patients with Active Rheumatoid Arthritis: EXTEND and MONARCH Open Label Extension Studies
    Burmester, Gerd
    Strand, Vibeke
    Kivitz, Alan
    Hu, Chih-Chi
    Wang, Sheldon
    van Hoogstraten, Hubert
    Tao, Ray
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3521 - 3525
  • [29] LONG-TERM SAFETY AND EFFICACY OF SARILUMAB OVER 5 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS REFRACTORY TO TUMOR NECROSIS FACTOR INHIBITORS
    Fleischmann, R.
    Genovese, M. C.
    Maslova, K.
    Leher, H.
    Praestgaard, A.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 620 - 621
  • [30] Long-term Safety and Efficacy of Sarilumab over 5 Years in Patients with Rheumatoid Arthritis Refractory to Tumor Necrosis Factor Inhibitors
    Fleischmann, Roy
    Maslova, Karina
    Leher, Henry
    Praestgaard, Amy
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2020, 72